Work

AML-498: Favorable Outcomes, Including Posttransplant Survival, Are Seen Independent of Baseline Skin Burden in Treatment-Naïve Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm Treated With Tagraxofusp: Subgroup Analysis of a Pivotal Trial

Year: 2026

Type: conference-abstract

Source: Clinical Lymphoma Myeloma & Leukemia

DOI: 10.1016/s2152-2650(26)01799-4

Authors: Eunice SWang, Andrew A Lane, Anthony S Stein, Sumithira Vasu, Todd L Rosenblat, David A Rizzieri, Marina Konopleva, John Katsetos, Alessandra Tosolini, Naveen Pemmaraju

Institutions: Roswell Park Comprehensive Cancer Center, Dana-Farber Cancer Institute, City Of Hope National Medical Center, City of Hope, The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Herbert Irving Comprehensive Cancer Center, Novant Health, Albert Einstein College of Medicine, Montefiore Einstein Comprehensive Cancer Center, The University of Texas MD Anderson Cancer Center

Language: English

Topic: Histiocytic Disorders and Treatments

Subfield: Physiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7204725002

Cites:

Cited by:

Related to: